Wells Fargo & Company Athira Pharma, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.24 - $4.15 $8 - $16	4 Added 1.71%	238 $0
Q4 2023 Feb 09, 2024	SELL	$1.39 - $2.46 $17,511 - $30,991	-12,598 Reduced 98.18%	234 $0
Q3 2023 Nov 13, 2023	SELL	$1.9 - $3.16 $3 - $6	-2 Reduced 0.02%	12,832 $25,000
Q2 2023 Aug 15, 2023	SELL	$2.36 - $3.59 $13,692 - $20,829	-5,802 Reduced 31.13%	12,834 $37,000
Q1 2023 May 12, 2023	BUY	$2.26 - $4.22 $13,618 - $25,429	6,026 Added 47.79%	18,636 $46,000
Q4 2022 Feb 13, 2023	SELL	$2.76 - $3.71 $184 - $248	-67 Reduced 0.53%	12,610 $39,000
Q3 2022 Nov 14, 2022	SELL	$2.93 - $3.96 $1,350 - $1,825	-461 Reduced 3.51%	12,677 $37,000
Q2 2022 Aug 12, 2022	SELL	$2.74 - $13.43 $7,861 - $38,530	-2,869 Reduced 17.92%	13,138 $40,000
Q1 2022 May 16, 2022	SELL	$8.96 - $13.51 $100,558 - $151,622	-11,223 Reduced 41.22%	16,007 $216,000
Q4 2021 Feb 14, 2022	BUY	$9.17 - $16.39 $248,782 - $444,660	27,130 Added 27130.0%	27,230 $354,000
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $40,973 - $49,661	-4,478 Reduced 97.82%	100 $1,000
Q2 2021 Aug 16, 2021	SELL	$10.24 - $20.87 $46,366 - $94,499	-4,528 Reduced 49.73%	4,578 $46,000
Q1 2021 May 13, 2021	SELL	$16.9 - $29.77 $5,441 - $9,585	-322 Reduced 3.42%	9,106 $167,000
Q4 2020 Feb 09, 2021	BUY	$16.48 - $34.3 $155,373 - $323,380	9,428 New	9,428 $324,000

22.8M

73.4K

97.8K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $15.9M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.